ZENITH Study - Clinical Research

Take Heart Health
to Heart

Learn about a clinical study for people with uncontrolled high blood pressure

About the ZENITH Study

The ZENITH study is evaluating an investigational medication for adults living with high blood pressure that isn't controlled.

The aim is to see if it can help lower blood pressure and reduce the risk of cardiovascular events, such as heart attack and stroke.

Research like this may help advance our understanding and care for people affected by uncontrolled high blood pressure and cardiovascular disease (CVD).

Who Is This For?

Adults 18 Years or Older

The study includes adults of all genders

Uncontrolled High Blood Pressure

Living with high blood pressure that isn't adequately controlled

You are an essential part of this research journey. Your participation may help advance medical knowledge and improve care for others.

You Matter

Your participation in ZENITH is valuable. By joining this study, you are helping to contribute to important medical research that may lead to better treatments for people living with uncontrolled high blood pressure.

Help Move Science Forward

Contribute to research that may lead to better treatments for high blood pressure and cardiovascular disease

Expert Medical Care

Receive close monitoring and care from experienced healthcare professionals throughout your participation

Compensation Provided

Receive compensation for your time and commitment to this important research

What is a Clinical Trial?

Clinical trials evaluate whether drugs, medical devices, or other medical treatments are safe and effective for human use.

In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products (such as drugs or devices), procedures, or changes to participants' diet or other behavior. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are currently available. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the clinical trial participants. For example, investigators may give a drug or treatment to participants who have high blood pressure to see whether their blood pressure decreases. All of these results are important because they advance medical knowledge and improve patient care.

Why Clinical Trials are Important?

In general, clinical studies are designed to add to medical knowledge related to the treatment, diagnosis, and prevention of diseases or conditions. Some common reasons for conducting clinical studies include:

Evaluating one or more interventions (for example, drugs, medical devices, approaches to surgery or radiation therapy) for treating a disease, syndrome, or condition.
Finding ways to prevent the initial development or recurrence of a disease or condition. These can include medicines, vaccines, lifestyle changes, or other approaches.
Evaluating one or more interventions aimed at identifying or diagnosing a particular disease or condition.
Examining methods for identifying a condition or risk factors for that condition.
Exploring and measuring ways to improve the comfort and quality of life of people with a chronic illness through supportive care.

Our goal at Metropolitan Cardiovascular Consultants is to further medical research by taking part in high-quality clinical studies. Our site has a long history of conducting clinical trials and has built a strong and solid reputation through exceptional patient care and data integrity. We are equipped with the latest technology and facilities to support a wide range of clinical research studies, especially in our areas of interest including cardiovascular diseases, metabolic diseases, and obesity.

Key highlights of our site include:

Experienced Team: Our research team consists of a number of exceptionally skilled and knowledgeable individuals, such as our Principal Investigator, Ayim Akyea-Djamson MD FACC, a Board Certified Cardiologist with 20 years of research experience. We also have three driven and experienced Study Coordinators, an on-site Phlebotomist, a part-time research nurse, PRN research nurses, and pharmacists. The integrity and success of every trial are our team's top priorities.

State-of-the-Art Facilities: We have a well-equipped location with the following services and equipment: several computers for safe data storage, a dedicated research office, exam rooms, and a robust EMR system with an audit trail and remote access capabilities. There is a centrifuge, freezers with temperatures as low as -20 and as high as -80, and refrigerators with continuous temperature monitors for IP storage, along with a state-of-the-art digital EKG system. Although, this is not a comprehensive list; we are also able to obtain any equipment needed for a particular investigation.

Diverse Patient Population: Our site has access to a broad and diverse patient population, enabling us to enroll and retain participants from various demographic backgrounds successfully. We consistently achieve strong representation from minority groups, ensuring inclusivity and diversity in our clinical trials. This diversity enhances the generalizability of study results and contributes to more comprehensive and representative research outcomes.

Strong Track Record: Our site has an established and proven record of successfully completing over 20 clinical trials across a range of therapeutic areas. We consistently meet or exceed key performance metrics, including enrollment targets, protocol adherence, and data quality. Our commitment to operational excellence and regulatory compliance ensures the timely and efficient execution of each study, contributing to reliable and impactful clinical research outcomes.